See also this year's filing and all EDGAR filings for this company.
PDF Report 0000858803_2013_Avanir_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000858803, Avanir Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 80,914,693 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,808,594 |
| 3 | remainder_Assets | 3,288,509 |
| 4 | LiabilitiesCurrent | 20,318,393 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 28,856,296 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 74,490,996 |
| 9 | ResearchAndDevelopmentExpense | 23,066,037 |
| 10 | remainder_Expenses | 3,508,763 |
| 11 | remainder_Revenues | 37,074,567 |
| 12 | remainder_NetIncome | 4,247,402 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 86,011,796 |
| 1 | Liabilities | 49,174,689 |
| 2 | Expenses | 101,065,796 |
| 3 | Revenues | 37,074,567 |
| 4 | StockholdersEquity | 36,837,107 |
| 5 | NetIncome | -59,743,827 |
| 6 | ComprehensiveNetIncome | -59,743,827 |
| 7 | BaseVar | 138,787,125 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.304 |
| 9 | EconomicCapitalRatio | 1.70 |
Edgar->Model Mapping
Feature Distribution
